Search by Drug Name or NDC
NDC 70934-0544-10 Sulfamethoxazole and Trimethoprim 800; 160 mg/1; mg/1 Details
Sulfamethoxazole and Trimethoprim 800; 160 mg/1; mg/1
Sulfamethoxazole and Trimethoprim is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The primary component is SULFAMETHOXAZOLE; TRIMETHOPRIM.
Product Information
| NDC | 70934-0544 |
|---|---|
| Product ID | 70934-544_d8500916-caf6-2622-e053-2995a90ac5f8 |
| Associated GPIs | 16990002300320 |
| GCN Sequence Number | 009396 |
| GCN Sequence Number Description | sulfamethoxazole/trimethoprim TABLET 800-160 MG ORAL |
| HIC3 | W2A |
| HIC3 Description | ABSORBABLE SULFONAMIDE ANTIBACTERIAL AGENTS |
| GCN | 90163 |
| HICL Sequence Number | 004071 |
| HICL Sequence Number Description | SULFAMETHOXAZOLE/TRIMETHOPRIM |
| Brand/Generic | Generic |
| Proprietary Name | Sulfamethoxazole and Trimethoprim |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sulfamethoxazole and Trimethoprim |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 800; 160 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | SULFAMETHOXAZOLE; TRIMETHOPRIM |
| Labeler Name | Denton Pharma, Inc. DBA Northwind Pharmaceuticals |
| Pharmaceutical Class | Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Dihydrofolate Reductase Inhibitor Antibacterial [EPC], Dihydrofolate Reductase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], Sulfonamide Antimicrobial [EPC], Su |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA090624 |
| Listing Certified Through | n/a |
Package
NDC 70934-0544-10 (70934054410)
| NDC Package Code | 70934-544-10 |
|---|---|
| Billing NDC | 70934054410 |
| Package | 10 TABLET in 1 BOTTLE, PLASTIC (70934-544-10) |
| Marketing Start Date | 2020-02-13 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |